Exploring early core symptoms in post-hepatectomy patients: a longitudinal study

Author:

Zhang Haoran1,Li Shaoxue1,Yuan Mengmeng1,Liu Jingya1,Fan Hua2,Li Shuwen1

Affiliation:

1. Anhui Medical University

2. The First Affiliated Hospital of University of Science and Technology of China

Abstract

Abstract Background: Patients with primary liver cancer (PLC) experience a range of symptoms in the early postoperative period. Symptoms include cancer-related symptoms and adverse effects of treatment. Exploring the core symptoms and their dynamics in the early post-hepatectomy patientsmay help provide better symptom management programs. Objective: The purpose of this study was to identify the core symptoms in early post-hepatectomy patients and to explore the trajectory of their dynamics. Methods: 249 participants with PLC underwent curative surgical procedures between March 2021 and September 2022 at the Hepatobiliary Surgery Departments of two Eastern Chinese hospitals. A comprehensive symptom assessment was administered to the patients 1-2 days after surgery (T1) and 1-2 days before discharge (T2). Network analysis was used to identify core symptoms in early post-hepatectomy patients based on symptom severity. Results: The network analysis identified the core symptoms of dry mouth, pain, abdominal distension, lack of appetite, and nausea at T1. In contrast, at T2, lack of appetite, pain, shortness of breath, and disturbed sleep were revealed. At the two early time points, while the results of the network structure test showed no statistically significant difference in the overall symptom network structure, there was a significant difference in the results for the core symptoms. Conclusion: Our study demonstrates the need to identify core symptoms in the early in early post-hepatectomy to improve symptom management in PLC patients. It is crucial to apply network analysis as an essential component of cancer care.

Publisher

Research Square Platform LLC

Reference57 articles.

1. Sung H, Ferlay J, Siegel RL, et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 71: 209–249. http://10.3322/caac.21660

2. Global burden of liver disease: 2023 update;Devarbhavi H;Journal of Hepatology.,2023

3. Disease Burden of Hepatocellular Carcinoma: A Global Perspective;Sayiner M;Digestive Diseases and Sciences.,2019

4. Global Epidemiology and Genetics of Hepatocellular Carcinoma;Toh MR;Gastroenterology.,2023

5. Xie Y (2017) Hepatitis B Virus-Associated Hepatocellular CarcinomaInfectious Agents Associated Cancers: Epidemiology and Molecular Biology, pp. 11–21.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3